SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001787306-22-000014
Filing Date
2022-03-03
Accepted
2022-03-03 16:09:36
Documents
15
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A arqt-20211231.htm   iXBRL 10-K/A 144204
2 RULE 13A-14(A) CERTIFICATION CEO exhibit313ceoq4202110ka.htm EX-31.3 10770
3 RULE 13A-14(A) CERTIFICATION CFO exhibit314cfoq4202110ka.htm EX-31.4 10745
  Complete submission text file 0001787306-22-000014.txt   413696

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20211231.xsd EX-101.SCH 2524
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20211231_lab.xml EX-101.LAB 41656
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20211231_pre.xml EX-101.PRE 22416
9 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20211231_htm.xml XML 21146
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39186 | Film No.: 22708757
SIC: 2834 Pharmaceutical Preparations